Clinical Drug Development for Rare Disease in Neurology (P2.194)

The goal of this project is to screen the approved orphan drug products in neurology and characterize the contents of the clinical pharmacology packages submitted to the drug applications. In addition, it was intended to identify the characteristics of the efficacy studies that supported the approval of these drug products and identify instances where FDA provided flexibility in reviewing these applications.